Ashleigh Hull
5PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Sep 07, 2023
Development of [225Ac]Ac-DOTA-C595 as radioimmunotherapy of pancreatic cancer: in vitro evaluation, dosimetric assessment and detector calibration.Ashleigh Hull, William Hsieh, Artem Borysenko
|Aug 14, 2023
In vitro characterisation of [177Lu]Lu-DOTA-C595 as a novel radioimmunotherapy for MUC1-CE positive pancreatic cancer.Ashleigh Hull, William Hsieh, William Tieu
|Oct 14, 2022
Preliminary Development and Testing of C595 Radioimmunoconjugates for Targeting MUC1 Cancer Epitopes in Pancreatic Ductal Adenocarcinoma.Ashleigh Hull, Yanrui Li, Dylan Bartholomeusz
|Dec 31, 2020
The Expression Profile and Textural Characteristics of C595-Reactive MUC1 in Pancreatic Ductal Adenocarcinoma for Targeted Radionuclide Therapy.Ashleigh Hull, Yanrui Li, Dylan Bartholomeusz
|Feb 26, 2020
Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma: A Review of the Current Status of Literature.Ashleigh Hull, Yanrui Li, Dylan Bartholomeusz
Pageof 1
